Survival benefit of primary prevention implantable cardioverter‐defibrillator/cardiac resynchronization therapy with a defibrillator: Analysis of the Japan cardiac device treatment registry and Japanese cardiac registry of heart failure in cardiology

Ähnliche Einträge

• A novel prediction model for survival in individual patients with cardiac resynchronization therapy with a defibrillator: Analysis of the new Japan cardiac device treatment registry database
  von: Hisashi Yokoshiki, et al.
  Veröffentlicht: (2025)
• Implantable cardiac defibrillator outcomes in octogenarians
  von: Bryan Stringer, et al.
  Veröffentlicht: (2025)
• Return‐to‐play in athletes with transvenous and subcutaneous implantable cardiac defibrillator: A meta‐analysis
  von: Rifqi Rizkani Eri, et al.
  Veröffentlicht: (2025)
• How to indicate implantable cardioverter‐defibrillator in the aging population
  von: Risako Orita, et al.
  Veröffentlicht: (2025)
• Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
  von: Yuki Konno, et al.
  Veröffentlicht: (2025)